RLAY logo

Relay Therapeutics (RLAY) Company Overview

Profile

Full Name:

Relay Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 16, 2020

Indexes:

Not included

Description:

Relay Therapeutics is a biotechnology company focused on developing innovative medicines using advanced protein analysis and drug discovery techniques. They aim to treat various diseases by understanding how proteins work and designing targeted therapies that can improve patient outcomes.

Key Details

Price

$3.21

Annual Revenue

$10.01 M(-60.83% YoY)

Annual EPS

-$2.36(+15.41% YoY)

Annual ROE

-44.15%

Beta

2.37

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 Stifel
Buy
Feb 27, 25 Goldman Sachs
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Dec 12, 24 JMP Securities
Market Outperform
Dec 5, 24 Leerink Partners
Outperform
Dec 4, 24 Leerink Partners
Outperform
Dec 4, 24 HC Wainwright & Co.
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 14, 24 HC Wainwright & Co.
Buy
Sep 17, 24 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Relay Therapeutics?
  • Does Relay Therapeutics pay dividends?
  • What sector is Relay Therapeutics in?
  • What industry is Relay Therapeutics in?
  • What country is Relay Therapeutics based in?
  • When did Relay Therapeutics go public?
  • Is Relay Therapeutics in the S&P 500?
  • Is Relay Therapeutics in the NASDAQ 100?
  • Is Relay Therapeutics in the Dow Jones?
  • When was Relay Therapeutics's last earnings report?
  • When does Relay Therapeutics report earnings?
  • Should I buy Relay Therapeutics stock now?

What is the ticker symbol for Relay Therapeutics?

The ticker symbol for Relay Therapeutics is NASDAQ:RLAY

Does Relay Therapeutics pay dividends?

No, Relay Therapeutics does not pay dividends

What sector is Relay Therapeutics in?

Relay Therapeutics is in the Healthcare sector

What industry is Relay Therapeutics in?

Relay Therapeutics is in the Biotechnology industry

What country is Relay Therapeutics based in?

Relay Therapeutics is headquartered in United States

When did Relay Therapeutics go public?

Relay Therapeutics's initial public offering (IPO) was on July 16, 2020

Is Relay Therapeutics in the S&P 500?

No, Relay Therapeutics is not included in the S&P 500 index

Is Relay Therapeutics in the NASDAQ 100?

No, Relay Therapeutics is not included in the NASDAQ 100 index

Is Relay Therapeutics in the Dow Jones?

No, Relay Therapeutics is not included in the Dow Jones index

When was Relay Therapeutics's last earnings report?

Relay Therapeutics's most recent earnings report was on Feb 26, 2025

When does Relay Therapeutics report earnings?

The next expected earnings date for Relay Therapeutics is May 2, 2025

Should I buy Relay Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions